Rhenium-188--a generator-derived radioisotope for cancer therapy.
Rhenium-188 (188Re) is an important therapeutic radioisotope which is obtained on demand as carrier-free sodium perrhenate by saline elution of the tungsten-188/rhenium-188 generator system. With a half-life of 16.9 hours and emission of a high energy beta particle (maximal energy of 2.12 MeV) and a gamma photon (155 keV, 15%) for imaging, 188Re can be provided at reasonable costs for routine preparation of radiopharmaceuticals for cancer treatment.
Knapp
F F
FF
Nuclear Medicine Group, Oak Ridge National Laboratory (ORNL), TN 37831-6229, USA. jkp@ornl/gov
D006207:Half-Life; D006801:Humans; D009369:Neoplasms / Q000532:radiotherapy*; D011868:Radioisotopes / Q000627:therapeutic use*; D019275:Radiopharmaceuticals / Q000138:chemical synthesis / Q000627:therapeutic use*; D012211:Rhenium / Q000627:therapeutic use*
D011868:Radioisotopes; D019275:Radiopharmaceuticals; D012211:Rhenium